期刊文献+

膀胱尿路上皮癌细胞株E2F3基因与miR-17—5p和miR-20a的相互作用 被引量:3

The correlation of E2F3, miR-17-5p and miR-20a in transitional cell carcinoma of bladder
原文传递
导出
摘要 目的研究E2F3基因、miR-17—5p和miR-20a在膀胱尿路上皮癌细胞株中的表达及相互影响,探讨E2F3基因与miR-17—5p和miR-20a在膀胱癌发生中的作用。方法用pcDNA3.1-HA—E2F3和pAAV—siRNA—E2F3质粒在膀胱癌细胞株5637中分别过表达和敲低E2F3基因,用miR-17-5p和miR-20a的模拟物和反义寡核苷分别过表达和敲低miR-17—5p和miR-20a后,实时荧光定量PCR法检测miR-17-5p、miR-20a和E2F3基因的变化,蛋白质印迹法检测E2F3蛋白水平的变化。结果E2F3基因过表达后,miR-17-5p和miR-20a的2值分别为2.26±0.30和4.044-0.51,与对照组(1.00±0.00)比较差异有统计学意义(P〈0.05);敲低E2F3后,miR-17—5p和miR-20a的2值分别为0.49±0.02和0.65±0.04,与对照组(1.00±0.00)比较差异有统计学意义(P〈0.05);同时过表达miR.17.5p和miR-20a,E2F3的mRNA水平明显下调,蛋白质平均灰度值为55.31±7.89,对照组为103.67±13.61,与对照组比较差异有统计学意义(P〈0.05);同时敲低miR17—5P和miR-20a后,E2F3的mRNA比对照显著上调,蛋白质平均灰度值为295.68±19.25,与对照组平均灰度值为103.67±13.61比较差异有统计学意义(P〈0.05)。结论E2F3基因可上调miR-17—5p和miR-20a的表达,miR-17—5p和miR-20a可以下调E2F3基因的表达。E2F3基因、miR-17—5p和miR.20a在膀胱尿路上皮癌中形成调节环路,协调膀胱肿瘤细胞的生长。 Objective To explore the correlation and role of E2F3 gene, miR-17-5p and miR-20a in the cell lines of transitional cell carcinoma of bladder. Methods The plasmids of pcDNA3.1-HA-E2F3 and pAAV-siRNA-E2F3 were used to overexpress and knockdown E2F3. The mimics of miR-17-5p, miR- 20a and their anti-miRNA oligonucleotides were used to overexpress and screen miR-17-5p and miR-20a. The expression levels of E2F3 gene, miR-17-5p and miR-20a were detected by quantitative real-time PCR, and E2F3 protein were detected by Western blot. Results When E2F3 was overexpressed, the 2-AACt of miR-17-5p and miR-20a were 2.26± 0.30 and 4.04± 0.51, it was statistically significant to compared with control (P 〈0.05) ; when E2F3 was knockdown, the 2 of miR-17-5p and miR-20a were 0.49 ±0.02 and 0.65 ± 0.04 (P 〈 0. 05) ; when miR-17-5p and miR-20a were overexpressed simultaneously, the level of E2F3 mRNA was significantly decreased, the average E2F3 protein gray scale was 55.31 ± 7.89, the control was 103.67 ± 13.61 (P 〈 0. 05 ) ; when miR-17-5p and miR-20a were knockdown simultaneously, the E2F3 mRNA was significantly increased, the E2F3 protein gray scale was 295.68 ±19.25, the control was 103.67 ± 13.61 ( P 〈 0.05 ). Conclusions miR-17-5p and miR-20a could be up-regulated by E2F3gene, and the E2F3 gene could be down-regulated by miR-17-5p and miR-20a. The regulatory feedback loop of E2F3 gene, miR-17-5p and miR-20a exists in transitional cell carcinoma of bladder. The loop maybe plays a key role in the development of bladder cancer.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2012年第4期264-267,共4页 Chinese Journal of Urology
基金 国家自然科学基金资助项目(30700834) 天津市科技计划项目(07zcGYsF05200)
关键词 E2F3基因 微小RNA 膀胱尿路上皮癌 基因调控 E2F3 gene Micro RNA Bladder neoplasms Gene regulation
  • 相关文献

参考文献13

  • 1Feber A,Clark J,Goodwin G. Amplification and overexpression of E2F3 in human bladder cancer[J].Oncogene,2004,(8):1627-1630.doi:10.1038/sj.onc.1207274.
  • 2Sylvestre Y,De Guire V,Querido E. An E2F/miR-20a autoregulatory feedback loop[J].Journal of Biological Chemistry,2007.2135-2143.
  • 3Woods K,Thomson JM,Hammond SM. Direct regulation of an oncogenic microRNA cluster by E2F transcription factors[J].Journal of Biological Chemistry,2006,(4):2130-2134.doi:10.1074/jbc.C600252200.
  • 4Bartel DP. MicroRNAs:Genomics,biogenesis,mechanism,and function[J].Cell,2004.281-297.doi:10.1016/S0092-8674(04)00045-5.
  • 5Knuutila S,Bj(o)rkqvist AM,Autio K. DNA copy number amplifications in human neoplasms:review of comparative genomie hybridization studies[J].American Journal of Pathology,1998.1107-1123.
  • 6O'Donnell KA,Wentzel EA,Zeller KI. c-Myc-regulated microRNAs modulate E2F1 expression[J].Nature,2005.839-843.doi:10.1038/nature03677.
  • 7Humbert PO,Verona R,Trimarchi JM. E2F-3 is critical for normal cellular proliferation[J].Genes and Development,2000.690-703.
  • 8Oeggerli M,Tomovska S,Schraml P. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer[J].Oncogene,2004,(33):5616-5623.doi:10.1038/sj.onc.1207749.
  • 9Coller HA,Forman JJ,Legesse-Miller A. "Myc' ed messages":Myc Induces Transcription of E2F1 while Inhibiting Its Translation via a microRNA Polyeistron[J].PLoS Genetics,2007.e146.doi:10.1371/journal.pgen.0030146.
  • 10Bartel DP. MicroRNAs:target recognition and regulatory functions[J].Cell,2009,(2):215-233.doi:10.1016/j.cell.2009.01.002.

二级参考文献10

  • 1吴登龙,张元芳,关明,刘薇薇,徐月敏,金三宝,金重睿,张炯,吕元.蛋白质芯片技术筛选膀胱癌尿液标记物的研究[J].中华泌尿外科杂志,2004,25(7):453-455. 被引量:16
  • 2骆明勇,田志刚,徐智,张亮,王应雄,程京.一种检测microRNA表达的微阵列芯片的研制及应用[J].生物化学与生物物理进展,2007,34(1):31-41. 被引量:14
  • 3Bartel DP. MicroRNAs: genomies, biogenesis, mechanism, and function. Cell, 2004, 116: 281-297.
  • 4He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A, 2005, 102: 19075-19580.
  • 5Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435: 834-838.
  • 6Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 2006, 103: 2257-2261.
  • 7Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let 7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res, 2004, 64: 3753-3756.
  • 8Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 2004, 101: 2999-3004_.
  • 9孙颖浩,杨庆,王林辉,许传亮,应康,唐榕,李瑶,钱松溪.人膀胱癌基因表达变化的基因芯片研究[J].中华泌尿外科杂志,2001,22(6):325-328. 被引量:9
  • 10周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生与前列腺癌患者血清总PSA水平与游离PSA比值的比较[J].中华泌尿外科杂志,2002,23(6):354-357. 被引量:74

共引文献7

同被引文献51

  • 1David P. Bartel.MicroRNAs: Target Recognition and Regulatory Functions[J].Cell.2009(2)
  • 2Benjamin P. Lewis,I-hung Shih,Matthew W. Jones-Rhoades,David P. Bartel,Christopher B. Burge.Prediction of Mammalian MicroRNA Targets[J].Cell.2003(7)
  • 3Allchorne P, Lamb B W, Kinsella J, et al. Initial experience of intra- vesical gemcitabine for patients with high-risk superficial transition- al cell carcinoma of the bladder following BCG failure [J]. Urol Nurs,2014,34(2) :95-99.
  • 4E1-Naggar M,Ebbing E, Bijnsdorp I, et al. Radiosensitization by thymi- dine phosphorylase inhibitor in thymidinephosphorylase negative and overexpressing bladder cancer cell lines[J]. Nucleotides Nucleic Acids, 2014,33(4/6) :413-421.
  • 5Jaiswal P K, Tripathi N, Shukla A, et al. Association of single nu- cleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk[J]. Med Oneol, 2013,30 (2) : 509.
  • 6Matsumura Y, Hanbury D, Smith J, et al. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoli- ated cancer cells[J]. BMJ, 1994,308(6929) : 619- 624.
  • 7Connell S, Meade K G, Allan B, et al. Genome-wide association a- nalysis of avian resistance to Campylobaeter jejuni colonization i: dentifies risk locus spanning the CDH13 gene[J]. G3 (Bethesda), 2013,3(5) :881-890.
  • 8Lin Y, Sun G, Liu X, et al. Clinical significance of T-cadherin Tissue expression in patients with bladder transitional cell carcinoma[J]. Urol Int,2011,86(3) :340-345.
  • 9Ozdemir E, Kakehi Y, Okuno H, et al. Role ofmatrixmetalloprotein- ase-9 in the basement membrane destruction of superficial urotheli- alcarcinomas[J]. J Urol, 1999,161 (4) : 1359 - 1363.
  • 10Offersen B V,Knap M M,Horsman M R,et al. Matrix metallopro- teinase-9measured in urine from bladder cancer patients is an inde- pendent prognostic marker of poor survival[J]. Acta Oncol, 2010, 49(8) : 1283- 1287.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部